Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-384
Closed -$94K 456
2022
Q3
$94K Sell
384
-2,594
-87% -$700K 0.01% 292
2022
Q2
$737K Sell
2,978
-36,225
-92% -$9.78M 0.05% 148
2022
Q1
$13M Sell
39,203
-77,491
-66% -$23.9M 0.65% 51
2021
Q4
$41.9M Sell
116,694
-30,831
-21% -$10.4M 1.89% 16
2021
Q3
$48M Sell
147,525
-12,870
-8% -$4.36M 2.04% 12
2021
Q2
$50.1M Sell
160,395
-1,904
-1% -$584K 2% 11
2021
Q1
$51.7M Sell
162,299
-10,619
-6% -$3.4M 2.2% 11
2020
Q4
$56.1M Buy
172,918
+12,719
+8% +$3.52M 2.5% 6
2020
Q3
$44.4M Buy
160,199
+9,373
+6% +$2.7M 2.22% 12
2020
Q2
$36.4M Buy
150,826
+39,615
+36% +$7.95M 2.34% 11
2020
Q1
$16.1M Buy
111,211
+41,418
+59% +$6.88M 1.28% 30
2019
Q4
$11.9M Buy
69,793
+43,368
+164% +$8.04M 0.73% 50
2019
Q3
$4.7M Buy
+26,425
New +$5.71M 0.3% 70

Other funds holding ABMD

TOBAM's ABMD Position: Q4 2022 in Review

TOBAM sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 384 shares — an estimated $94K sold.

TOBAM first reported a position in ABMD in Q3 2019 and held it in 13 quarters. The position peaked at $56.1M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • TOBAM reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • TOBAM sold 384 Abiomed Inc shares in Q4 2022, an estimated $94K.
  • TOBAM first reported a position in Abiomed Inc in Q3 2019 and held it in 13 quarters.
  • TOBAM's Abiomed Inc position peaked at $56.1M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on TOBAM's 13F filing for Q4 2022, filed 2 Feb 2023.